Patents by Inventor Gertrudis Carmeliet

Gertrudis Carmeliet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Placental growth factor as a target for the treatment of osteoporosis
    Patent number: 7357929
    Abstract: This invention relates to antagonists of placental growth factor and signalling thereof, pharmaceutical compositions containing such antagonists and the use of such antagonists to prevent bone loss or bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass and/or bone defects in vertebrates, and particularly mammals, including humans.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: April 15, 2008
    Assignees: D. Collen Research Foundation VZW, K.U. Leuven Research & Development, Vlaams Interuniversitair Instituut Voor Biotechnologie VZW
    Inventors: Peter Carmeliet, Désiré Collen, Roger Bouillon, Gertrudis Carmeliet
  • Use of antibodies against FLT-1 for the treatment of osteoporosis
    Publication number: 20050186204
    Abstract: This invention relates to antagonists of the placental growth factor receptor and signaling thereof, pharmaceutical compositions containing such antagonists and the use of such antagonists to prevent bone loss or bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass and/or bone defects in vertebrates, and particularly mammals, including humans.
    Type: Application
    Filed: December 27, 2004
    Publication date: August 25, 2005
    Inventors: Peter Carmeliet, Desire Collen, Roger Bouillon, Gertrudis Carmeliet
  • Placental growth factor as a target for the treatment of osteoporosis
    Publication number: 20050175609
    Abstract: This invention relates to antagonists of placental growth factor and signalling thereof, pharmaceutical compositions containing such antagonists and the use of such antagonists to prevent bone loss or bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass and/or bone defects in vertebrates, and particularly mammals, including humans.
    Type: Application
    Filed: June 27, 2003
    Publication date: August 11, 2005
    Inventors: Peter Carmeliet, Desire Collen, Roger Bouillon, Gertrudis Carmeliet